BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15501368)

  • 1. Cognitive issues in Parkinson's disease.
    Elmer L
    Neurol Clin; 2004 Oct; 22(3 Suppl):S91-S106. PubMed ID: 15501368
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
    Gallini A; Sommet A; Salandini AM; Veyssière P; Montastruc JL; Montastruc JL
    Mov Disord; 2007 Oct; 22(13):1980-1. PubMed ID: 17657810
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.
    Aarsland D
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S144-8. PubMed ID: 26411499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease].
    Krüger R; Weiss D
    MMW Fortschr Med; 2011 Apr; 153(14):29-32; quiz 33. PubMed ID: 21966866
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lewy body dementia and Parkinson disease dementia].
    Meyniel C; Damier P
    Presse Med; 2007 Oct; 36(10 Pt 2):1485-90. PubMed ID: 17572053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "closing-in" phenomenon in Parkinson's disease dementia and lewy-body dementia.
    Poletti M; Lucetti C; Del Dotto P; Borelli P; Baldacci F; Logi C; Bonuccelli U
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E38-9. PubMed ID: 23224479
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
    Larsson V; Engedal K; Aarsland D; Wattmo C; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2011; 32(4):227-34. PubMed ID: 22122992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconsidering diagnostic criteria for dementia with lewy bodies. Highlights from the Third International Workshop on Dementia with Lewy Bodies and Parkinson's Disease Dementia, September 17-20, 2003, Newcastle Upon Tyne, United Kingdom.
    Cummings JL
    Rev Neurol Dis; 2004; 1(1):31-4. PubMed ID: 16397449
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroprotective agents in Parkinson's disease: clinical evidence and caveats.
    Hälbig TD; Tse W; Olanow CW
    Neurol Clin; 2004 Oct; 22(3 Suppl):S1-S17. PubMed ID: 15501359
    [No Abstract]   [Full Text] [Related]  

  • 13. Future therapies for Parkinson's disease.
    Hauser RA; Lyons KE
    Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's disease.
    Levy JA; Chelune GJ
    J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):227-38. PubMed ID: 18004009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychotic disorders in Parkinson's disease and dementia with Lewy bodies].
    Levin OS; Anikina MA; Shindriaeva NN; Zimniakova OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(6):82-8. PubMed ID: 21905342
    [No Abstract]   [Full Text] [Related]  

  • 16. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
    Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Parkinson's disease.
    Schapira AH
    Eur J Neurol; 2008 Jan; 15(1):1. PubMed ID: 18171385
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive dysfunction in early onset parkinsonism.
    Tsai CH; Lu CS; Hua MS; Lo WL; Lo SK
    Acta Neurol Scand; 1994 Jan; 89(1):9-14. PubMed ID: 8178636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease.
    Burn DJ; McKeith IG
    Mov Disord; 2003 Sep; 18 Suppl 6():S72-9. PubMed ID: 14502659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.